PosterSessionOnline

BRITISH SOCIETY FOR HAEMATOLOGY

66th Annual Scientific Meeting of the British Society for Haematology

19-21 April, Liverpool

N. Poster

Poster title

Applicant name

Status


1-P	T cell resistance to glucocorticoids in graft-versus-host disease	Lisanne Schoutens	Received

1-EP	Evaluating prognostic value of CD15 and CD3 donor chimerism after allogeneic transplantation in myeloid disease.	Robert Bain	Received

1-EP	Clinical Effectiveness and Safety of Belumosudil in Refractory Chronic Graft-Versus-Host Disease: A UK Single-Centre Cohort	Vismay Deshani	Received

1-EP	THE ROLE OF TGF?1 IN THE HEMATOLOGICAL TUMOR MICROENVIRONMENT IN PATIENTS WITH ACUTE LEUKEMIA	Vira Barilka	Received

1-EP	Sweet´s Syndrome in Acute Myeloid Leukaemia During Post-Cytotoxic Neutropenia: A Rare Onco-Haematology Complication	Gayathri Gamage	Received

1-EP	Paediatric Acute Lymphoblastic Leukaemia: a retrospective review of coagulation tests at diagnosis.	Rochana Redkar	Received

1-EP	Outcomes of Induction Therapy in Newly Diagnosed Acute Myeloid Leukemia in a LMIC Setting	Chaitanya H Balakrishnan	Received

1-EP	UHS NGS Panel Predicts Disease Recurrence Significantly Earlier Than Existing Technologies in a Retrospective AML Study	Graham Speight	Received

1-EP	Brexucabtagene Autoleucel Real-World Manufacturing Experience for Adult Acute Lymphoblastic Leukaemia in the United Kingdom	Michelle Lannon	Received

1-EP	A Study Assessing the Relationship Between Positive MDRO Screening and Sepsis in Allogenic HSCT Patients.	Susannah Louis	Received

1-EP	Immunophenotypic Analysis of B-cell Acute Lymphoblastic Leukaemia at a Tertiary Care Hospital in Sri Lanka	Chitranga Kariyawasan	Received

1-EP	Real-World Outcomes of Venetoclax-Based Therapy in Acute Myeloid Leukaemia: Multi-Centre Study in South Wales, UK	Sahil Bhagat	Received

1-EP	Venetoclax and Azacitidine in Acute Myeloid Leukaemia: Real-World Patient Outcomes and Supportive Care Needs	Henry Simons	Received

1-EP	Karyotype vs Fast FISH: The Myeloid Matrix	Katie Stark	Received

1-EP	Outcomes of Adult Admissions with Acute Myeloid Leukaemia Complicated by Tumour Lysis Syndrome	Tarek Raad	Received

1-EP	"Outcomes After Allogeneic Haematopoietic Cell Transplantation in AML-MR and MDS: A Single-Centre Retrospective Analysis"	Thwe Han	Received

1-EP	Single centre experience on vaccination uptake in adults post-haematopoietic stem cell transplantation for B-cell malignancies	Aashir Akram	Received

1-EP	Febrile Neutropenia, Time to Antibiotics and Associated Clinical Outcomes in Haemato-oncology	Amy Grobbelaar	Received

1-EP	The Link Between Allogeneic Stem Cell Transplantation and Sarcopenia: A Comprehensive Literature Review	Rebecca Stacey	Received

1-P	Safety and efficacy of Surovatamig (AZD0486) in relapsed/refractory B-cell acute lymphoblastic leukaemia (B-ALL): SYRUS study	Anna Castleton	Received

1-EP	Induction Regimens and Responses in Acute Myeloid Leukemia: Data from a Low-to-Middle Income Country.	Zeeshan Majeed	Received

1-P	Feasibility of Ambulatory Blinatumomab Administration in Treated B-Cell Acute Lymphoblastic Leukaemia: A Single-Centre Retrospective Review	Paul OConnor	Received

1-P	Molecular Dynamics of PU.1 and Annexin A1 in Acute Promyelocytic Leukaemia Cells Following ATRA/ATO Therapy	Tunch Akmandor	Received

1-EP	Transcriptional Modulation of Differentiation-Associated Markers During ATRA and ATO Treatment in Acute Promyelocytic Leukaemia Cells	Tunch Akmandor	Received

1-EHA26-PO	In Vitro and In Silico Antisickling Activity of Theobroma cacao L. Stem Bark Extracts	Samuel Badekale	Received

1-EP	Venetoclax and Azacitidine in Relapsed Acute Myeloid Leukaemia: Outcomes From a Single UK Centre	Danyal Khan	Received

1-P	Post-transplant Sorafenib maintenance for FLT3-ITD mutated Acute Myeloid Leukaemia: The South Wales transplant programme experience	Emily Booth	Received

1-P	Equivalent outcomes after reduced intensity, T-replete HSCT with haploidentical donors and truly non-myeloablative MUD HSCT	Peter Johnstone	Received

1-EP	Allogeneic transplant outcomes in patients with secondary or therapy-related AML treated with CPX-351 in Scotland	Paula Glancy	Received

1-P	The Impact of Genomic Tumour Advisory Board and WGS on management of patients with T-ALL/LBL	Yashashree Gupta	Received

1-P	An Investigation of Antimicrobial Prophylaxis Practices in UK/ROI Allogeneic Haematopoietic Stem Cell Transplant Centres	Nick Duncan	Received

1-P	ALL-ORAL DECITABINE-CEDAZURIDINE + VENETOCLAX IN NEWLY DIAGNOSED AML INELIGIBLE FOR INDUCTION CHEMOTHERAPY: PHASE 1/2 RESULTS	Arslan Rehman	Received

1-P	Time at Home for Patients With Secondary AML Treated With CPX-351 or Venetoclax-Azacitidine in England	Sameerah Bashir	Received

1-P	Pooled Analysis of CPX-351 Effectiveness and Safety in Younger Patients With Secondary Acute Myeloid Leukaemia	Sameerah Bashir	Received

1-EP	Myelodysplasia related genetics predict inferior outcomes in venetoclax treated AML: a single centre experience	Amardass Dhami	Received

1-P	INO-TRANSIT: Real-world outcomes with inotuzumab ozogamicin prior to CAR-T cell therapy in relapsed/refractory B-cell ALL	Anna Castleton	Received

1-P	Outcomes in Gilteritinib-Treated Patients with Relapsed/Refractory FLT3mut+ AML Post-HSCT: Analysis from ADMIRAL and COMMODORE	Jaymini Patel	Received

1-EP	Successful Blinatumomab Bridge to Maintenance in Down Syndrome–Associated Acute Lymphoblastic Leukemia: Blinatumomab Institutional Experience	Alyaa Al Mughairy	Received

1-EP	Repurposing Alendronate, Allopurinol, and Balsalazide to Overcome Cytarabine Resistance: CD45-Targeted Strategy in Omani AML Patients	Maryam Al Barashdi	Received

1-EP	Genetic Testing for Acute Myeloid Leukaemia: A National and Local Guideline Compliance Audit	Michael King	Received

1-EP	Acute Promyelocytic Leukaemia in the North East and Cumbria: A Regional Update	Harry Wilson	Received

1-EP	Therapy Professionals in Allogeneic Stem Cell Transplants: A UK Wide Workforce Survey	Abigail Sayers	Received

1-EP	Assessment of Minimal Residual Disease (MRD) in Acute Lymphoblastic Leukaemia (ALL) by Flow Cytometry	Tanzia Tompa	Received

1-EP	Re-Audit: Central Line Contamination and Calcineurin Inhibitor Monitoring in Allogeneic Stem Cell Transplant Patients	Danushka Dissanayake	Received

2-EP	Understanding Instructive Cytokine Signalling in Preleukaemic Haematopoietic Stem Cells	Charlotte Elizabeth Titterington-Colman	Received

2-EP	VEXAS syndrome presenting as relapsing polychondritis with clonal haematopoiesis	Praveen Kumar Kaudlay Sathyanarayana	Received

2-P	Understanding the Sexual Health Burden in Individuals Living with Myeloproliferative Neoplasms	Claire woodley	Received

2-P	Consistent Benefits of Pegcetacoplan in patients with PNH: Analysis of COMPLETE Phase 4 Observational Study	Roochi Trikha	Received

2-P	Danicopan add-on to ravulizumab or eculizumab in PNH patients stratified by bone marrow failure history	Morag Griffin	Received

2-EP	Bomedemstat for Polycythemia Vera Resistant or Intolerant to Cytoreductive Therapy: Phase 2 Shorespan-004 Study	Charlotte Brennan	Received

2-P	Complement Regulation in Paroxysmal Nocturnal Haemoglobinuria: Factor H and I Levels in Breakthrough Haemolysis	Matthew Holt	Received

2-P	Factor Bb and sC5b-9 as Biomarkers of Breakthrough Haemolysis in Paroxysmal Nocturnal Haemoglobinuria	Matthew Holt	Received

2-P	Association Between Momelotinib Exposure and Haemoglobin Improvement in Myelofibrosis Patients with Anaemia: MOMENTUM Subanalysis	Joanne Ewing	Received

2-EP	Dual transfusion independence and spleen reduction improve overall survival in myelofibrosis patients treated with momelotinib	Bethan Psaila	Received

2-EP	Survival outcomes in myelofibrosis patients switching from ruxolitinib to momelotinib using RR6 model	Frances Wadelin	Received

2-P	New or worsening anaemia or thrombocytopenia affects outcomes in JAKi-naive myelofibrosis patients treated with ruxolitinib	Frances Wadelin	Received

2-P	TFR in CML using Imatinib while employing Modified Eligibility Criteria	Hafiz Shafi	Received

2-P	Impact of Haemoglobin Improvement With Momelotinib on Survival in Patients With Myelofibrosis and Anaemia	Donal McLornan	Received

2-P	Avapritinib Continues to Demonstrate Durable Symptom Control With a Well-Tolerated Safety Profile: Long-Term Outcomes from PIONEER	Deepti H. Radia	Received

2-P	Improving Quality of Life and Death in Haematological Malignancies: 2026 Parallel Planning Clinic Update	Jayne Osborne	Received

2-P	Unmet Needs and Communication Gaps in the Myelofibrosis Patient Experience: Results of EXPLORE-MF Research	Claire Woodley	Received

2-EP	Systemic Challenges in the UK Myelofibrosis Clinical Pathway: Results of EXPLORE-MF Research	Ioannis Koutsavlis	Received

2-P	Bexmarilimab Plus Azacitidine in Higher Risk Myelodysplastic Syndrome: Updated Results from the BEXMAB Study	Sofia Aakko	Received

2-EHA26-PO	Redefining Normal: A National Systematic Review and Meta-analysis of Haematological Reference Intervals in Indian Adults	Shriya Karlapudi	Received

2-P	Secondary Primary Malignancy After Imatinib Treatment of Chronic Myeloid Leukaemia: A Retrospective Population-Based Study	Eniola Renner	Received

2-EP	Correlation of Symptom Burden against Disease Characteristics and Thrombotic Events in Myelofibrosis Patients	Benissa Narciso	Received

2-EP	Methodological Limitations of Prognostic Models for Myeloid Malignancies: A Systematic Review and Critical Appraisal	Jyoti Sehjal	Received

2-EP	Combination of Cyclosporine and Eltrombopag as a First-Line Therapy in patients with Aplastic Anemia.	Aritra Saha	Received

2-EP	Qualitative Analysis of the impact of Menopause in Women with Myeloproliferative Neoplasms: Single Centre Survey	Priya Sriskandarajah	Received

2-EP	Preliminary Insights into Immunosuppressive Therapy and Eltrombopag in Hypoplastic Myelodysplastic Syndrome	Thi Thu Hien Dao	Received

2-EP	Is it safe and feasible for new erythrocytosis patients to get pre-clinic blood tests?	Morgan Sands	Received

2-P	Treatment disruption during pegylated interferon shortage: an international patient survey	Llywelyn Cadman-davies	Received

2-EP	Distinct Molecular Landscape of a South Indian AML cohort: Younger Age, Adverse Biology	Chaitanya H Balakrishnan	Received

2-EP	Therapeutic Impact of BET-Inhibition on Immune Cell Death Checkpoints in MPN	Matt Simmonds	Received

2-EP	Myeloproliferative Neoplasms associated with Cerebral Venous Sinus thrombosis: Retrospective Review from UK Tertiary Centre	Tarik Rosun	Received

2-EP	Pancreatic Myeloid Sarcoma Mimicking Pancreatic Carcinoma	Parth Ganatra	Received

2-P	Rare, predicted impactful GATA2 variants do not predict GATA2 deficiency syndrome phenotypes in a large genomic dataset	Pietro Vassallo	Received

2-EP	Immune Evasion in Myelodysplastic Syndrome: Investigating the potential of immunotherapy in enhancing macrophage phagocytosis	Matt Simmonds	Received

2-P	Multicentre UK Audit of Symptom Burden in Patients with Indolent Systemic Mastocytosis Utilising the ISM-SAF©	Sneha Fernandes	Received

2-P	Asciminib is most effective for patients with CP-CML who fail previous therapy due to intolerance	Kevin Joyce	Received

3-P	Cognitive frailty, an Under-recognised Aspect of the Frailty Phenotype in Multiple Myeloma	Sumayyah Patel	Received

3-EP	Dexamethasone dosing in daratumumab-lenalidomide-dexamethasone and lenalidomide-dexamethasone in newly diagnosed non-transplantable multiple myeloma	Peter Thom	Received

3-EP	Integrating Geriatric Expertise into Myeloma Care: Findings from a Joint Haematology-Geriatrician Pilot Clinic	Joanna Preston	Received

3-EP	Patients´ Perceptions of On-body Injectors; an Exploratory Investigation	Catherine Loughran	Received

3-EP	Cost effectiveness analysis of Denosumab vs Zoledronate for Bone Protection in Multiple Myeloma	Micheal Brennan	Received

3-EP	Safe transition to outpatient bispecific antibody therapies in myeloma using Virtual Ward: a single-centre study	Victor Ling	Received

3-P	Prolonged elranatamab treatment interruption in patients with relapsed/refractory multiple myeloma: A MagnetisMM-3 retrospective analysis	Emma Searle	Received

3-EP	MGUS monitoring >90 years old- age is just a number	Susannah Olive	Received

3-EP	Chimeric Antigen Receptor T-Cell Therapy in Multiple Myeloma: Efficacy, Barriers, and Pathways Toward Standard Treatment	Rachel Fletcher	Received

3-EP	Clinical Utility of Pre-ASCT Bone Marrow Biopsy in Multiple Myeloma	Jemma Larham	Received

3-EP	UK Nurses´ and Pharmacists´ Preferences for On-Body Injectors Compared with Manual Syringes in Subcutaneous Delivery	Catherine Loughran	Received

3-EP	Belantamab mafodotin, pomalidomide and dexamethasone: UK treatment effectiveness in relapsed/refractory multiple myeloma	Adil Merchant	Received

3-EP	Belantamab mafodotin, bortezomib and dexamethasone: UK treatment effectiveness in relapsed/refractory multiple myeloma	Adil Merchant	Received

3-EP	Transplant decision-making in newly diagnosed multiple myeloma treatment: A UK cross-sectional study of healthcare providers	Neil Rabin	Received

3-P	Treatment Priorities of Patients With Relapsed/Refractory Multiple Myeloma and Healthcare Providers in the UK	Rakesh Popat	Received

3-EP	Significance of Using Renal-adjusted Reference Ranges When Risk-Stratifying MGUS	Sarah Jones	Received

3-EP	Identifying which Clinical and Biochemical factors Predict Outcome in Multiple Myeloma	Rory Pinkney	Received

3-EP	Pre-autograft lung function testing in patients with myeloma: audit of practice suggests over-investigation	Graham McIlroy	Received

3-EP	Radiotherapy for Oligo-progressive Myeloma Enables Clinically Meaningful Extension of Systemic Therapy: Single Centre Retrospective Analysis	Oshani Kekulawala	Received

3-EP	Blood Product Utilisation Following Melphalan-Conditioned Autologous Stem Cell Transplantation for Myeloma	Tom Clay	Received

3-EP	Melphalan dosing in autologous stem cell transplant. Should we still dose adjust for older patients?	Rebecca Lloyd	Received

3-P	Daratumumab in transplant-eligible newly-diagnosed multiple myeloma: analysis of sustained minimal residual disease negativity in PERSEUS	Emma Rogers	Received

3-P	Daratumumab Monotherapy Versus Active Monitoring in Patients With High-Risk Smoldering Multiple Myeloma: AQUILA Study Outcomes	Emma Rogers	Received

3-P	Safety and efficacy of AZD0120 BCMA/CD19 CAR-T in relapsed/refractory myeloma: DURGA-1 Phase 1b/2 preliminary results	Simon Rule	Received

3-P	Earlier Use of Ciltacabtagene Autoleucel (Cilta-cel) Correlates With Better Immune Outcomes in CARTITUDE-4	Emma Rogers	Received

3-EP	Evaluating the Necessity of Antifungal Prophylaxis in Multiple Myeloma: A Single-Centre Retrospective Review	Ramandeep Puni	Received

3-P	REALiTEC-2: International Observational Retrospective Study of Teclistamab in Relapsed/Refractory Multiple Myeloma in the Real World	Emma Rogers	Received

3-P	Daratumumab-Bortezomib-Lenalidomide-Dexamethasone in Transplant-Ineligible Newly Diagnosed Multiple Myeloma: Results from Systematic Literature Review and Network Meta-Analysis	Emma Rogers	Received

3-P	Risk stratification in newly-diagnosed myeloma: Is a sequencing panel a cost-effective option for the NHS?	Liz Morrell	Received

3-P	Relapse Kinetics and Treatment Decision-Making in Multiple Myeloma: A Single-Centre Experience	Olivia Birkett	Received

3-EP	The EXACT System for Precision Clinical Trial Matching: Study of Accuracy with Multiple Myeloma Trials	Adam Blum	Received

3-P	Long-term (=5 year) Remission and Survival With Relapsed/Refractory Multiple Myeloma Following Ciltacabtagene Autoleucel Treatment: CARTITUDE-1	Emma Rogers	Received

3-EP	Misalignment of Treatment Goals Between Patients With Multiple Myeloma and Healthcare Professionals: a Cross-Sectional Study	Arlyn Baasis	Received

3-EP	Cytomegalovirus, Adenovirus and Epstein-Barr Virus Viraemias in Patients with Relapsed Myeloma Treated with T-cell Engagers	Jessica Wong	Received

3-P	Minimal residual disease-negativity in patients with relapsed/refractory multiple myeloma treated with belantamab mafodotin in DREAMM-8	Kevin Boyd	Received

3-P	DREAMM-7: long-term responders with belantamab mafodotin (BVd) versus daratumumab (DVd) combinations in relapsed/refractory multiple myeloma	Muhammad Yasin Kureeman	Received

3-P	DREAMM-7 and -8: Functional high-risk relapsed/refractory multiple myeloma subgroup outcomes with belantamab mafodotin	Muhammad Yasin Kureeman	Received

3-EP	Ophthalmic Examination Findings and Impact on Reading/Driving in Relapsed/Refractory Multiple Myeloma Patients on Belantamab Mafodotin	Muhammad Yasin Kureeman	Received

3-P	Ciltacabtagene Autoleucel Out-of-Specification Manufacturing Outcomes Improve With Earlier Lines of Therapy	Emma Rogers	Received

3-P	Long-Term Progression-Free Survival Benefit With Ciltacabtagene Autoleucel in Standard-Risk Relapsed/Refractory Multiple Myeloma	Emma Rogers	Received

3-P	Transplant-Ineligible Patients with NDMM in the Phase 3 MAIA and CEPHEUS Trials: Dynamic Frailty Analysis	Emma Rogers	Received

3-P	Effectiveness of Bridging Therapy and Improved Outcomes After Ciltacabtagene Autoleucel in CARTITUDE-4	Emma Rogers	Received

3-P	Talquetamab With Pomalidomide in Patients With Relapsed/Refractory Multiple Myeloma (RRMM): Updated Safety/Efficacy From MonumenTAL-2	Emma Rogers	Received

3-P	Real-World Multicentre Experience of Rapid Rate Isatuximab Infusions in Patients with Multiple Myeloma	Grant Mehrjou	Received

3-P	Ciltacabtagene autoleucel vs Standard of Care in Relapsed/Refractory Multiple Myeloma Treatment: CARTITUDE-4 Survival Subgroup Analyses	Emma Rogers	Received

3-P	Quality-Adjusted Survival Analysis of Neurologic Events With Ciltacabtagene Autoleucel in Multiple Myeloma: CARTITUDE-4 Population	Emma Rogers	Received

3-P	Analysis by Complete Response and Prior BCMA-Targeted Therapy in Patients from the Observational REALiTAL Study	Emma Rogers	Received

3-EP	Talquetamab Safety in REALiTAL, a Real-World Observational Study of Patients with Relapsed/Refractory Multiple Myeloma	Emma Rogers	Received

3-EP	Measurement of Talquetamab-Associated Dysgeusia in Relapsed/Refractory Multiple Myeloma using WETT-SA53: TALISMAN Study Preliminary Data	Emma Rogers	Received

3-EP	Daratumumab, Lenalidomide and Dexamethasone in Real-World Practice	Thea Chandler	Received

3-EP	Frequency of PICC Line–Associated Venous Thromboembolism in Multiple Myeloma Patients Undergoing Autologous Stem Cell Transplant	Kanta Devi	Received

3-EP	The Pitfalls of Monitoring Monoclonal Gammopathy of Undetermined Significance (MGUS): an Audit	Kate Matthews	Received

3-EP	The Increasing Burden of Monitoring Monoclonal Gammopathy of Undetermined Significance (MGUS): an Audit	Kate Matthews	Received

3-EP	Characterisation of Infections in Patients With Relapsed/Refractory Multiple Myeloma Treated With Belantamab Mafodotin–Based Regimens	Muhammad Yasin Kureeman	Received

3-P	Belantamab treatment of multiple myeloma: results from the first-in-human phase 1/2 DREAMM-20 trial	Muhammad Yasin Kureeman	Received

3-EP	Belantamab Mafodotin Combination Therapy for Transplant-Ineligible Newly-Diagnosed Multiple Myeloma: Results of the Phase 1 DREAMM-9 Study	Mamta Garg	Received

3-EP	Feasibility and Acceptability of Continuous Wearable Monitoring During Autologous Stem-Cell Transplantation: The MY-TRAC Study	Tommy Brown	Received

4-EP	Ovarian Non-Hodgkin Lymphoma Presenting As Advanced Ovarian Cancer: A single Centre Experience	Mohammed Abdelsalam	Received

4-EP	Accelerated Chronic Lymphocytic Leukaemia Complicated by Bilateral Pathological Humeral Fractures	Mariyum Khawar	Received

4-EP	Angioimmunoblastic T-Cell Lymphoma Presenting with Autoimmune Hemolysis and EBV Viremia in Elderly Female: Diagnostic Challenge	Amir Hayat	Received

4-EP	Effectiveness of Patient-Reported Outcome Measures in Capturing Quality of Life: Aggressive vs Indolent Non-Hodgkin Lymphoma	Saffron Hayer	Received

4-EP	Hodgkin Lymphoma Presenting With Unusual Neurological Symptoms: A Case Report	Nagah Elmusharaf	Received

4-P	TRANSCEND FL: Three-Year Follow-up of Lisocabtagene Maraleucel in Patients With Third-Line or Later Follicular Lymphoma	Alex Verdeur	Received

4-P	Sonrotoclax in Patients With Relapsed/Refractory Mantle Cell Lymphoma and Previous Bruton Tyrosine Kinase Inhibitor Treatment	Toby Eyre	Received

4-P	Zanubrutinib Is Well Tolerated and Effective in Acalabrutinib-Intolerant Patients With B-Cell Malignancies: A Long-Term Follow-Up	Dee Rodeberg	Received

4-EP	Long-term Outcomes with Lisocabtagene Maraleucel in Patients With Second-Line Large B-Cell Lymphoma from TRANSFORM	Alex Verdeur	Received

4-EP	Characterizing and Targeting Follicular Lymphoma´s Common Progenitor Cells	Oscar Atkins	Received

4-EP	Updated Safety Run-In Results: LOTIS-5 Phase 3 Trial of Loncastuximab + Rituximab in R/R DLBCL	Pam McKay	Received

4-EP	Initial Results From LOTIS-7: Phase 1b Study of Loncastuximab Tesirine + Glofitamab in R/R DLBCL	Graham Collins	Received

4-EP	Head and Neck Involvement in Mycosis Fungoides: The Role of Speech and Language Therapy	Philippa MacDonnell	Received

4-EP	Real-world effectiveness of mogamulizumab in Spain and Portugal: second interim analysis of the MIBERIC study	Sara Ali	Received

4-EP	Updated interim results from the German MINT study	Sara Ali	Received

4-EP	Patient-reported symptoms and HRQoL of MF and SS patients receiving mogamulizumab: interim results from PROSPER	Sara Ali	Received

4-EP	Demographic, Disease and Treatment Characteristics of Patients with CLL/SLL in England: A Retrospective Database Analysis	Renata Walewska	Received

4-EP	Assessing Levels of Mental Health Support in Lymphoma Patients Using Patient Reported Outcomes (PROs)	Harry Brewster	Received

4-P	6-Year Follow-up of Zanubrutinib in Relapsed/Refractory Chronic Lymphocytic Leukemia or Small Lymphocytic Lymphoma	Moya Young	Received

4-P	Epcoritamab Long-Term Disease Control in Large B-Cell Lymphoma with Prior Chimeric Antigen Receptor T-Cell Therapy	Sophie Barnwell	Received

4-P	Patient-Reported Outcomes in Patients with Relapsed/Refractory Follicular Lymphoma Treated with Epcoritamab within Entire Study Cohort	Sophie Barnwell	Received

4-EP	Durable Responses in Large B-Cell Lymphoma Patients in Complete Response who Paused or Discontinued Epcoritamab	Sophie Barnwell	Received

4-P	Treatment Effectiveness in CLL Patients Receiving Venetoclax-Based Therapy After Progression on a Covalent BTKi	Sophie Barnwell	Received

4-EP	Real-World Effectiveness of Venetoclax-Obinutuzumab versus Second-Generation Bruton Tyrosine Kinase Inhibitors in Frontline Chronic Lymphocytic Leukemia	Sophie Barnwell	Received

4-EP	Real-World Treatment Outcomes among Patients with High-Risk CLL/SLL Receiving Venetoclax-Based Therapy in 1L or 2L	Sophie Barnwell	Received

4-EP	Sustained Efficacy of Zanubrutinib vs Bendamustine+Rituximab: 6-Year Follow-Up in the Phase 3 SEQUOIA Study	Talha Munir	Received

4-P	Phase 2 BELLWAVE-003 Cohort F: Updated Clinical Outcomes of Nemtabrutinib in Relapsed or Refractory Marginal Zone Lymphoma	Charlotte Brennan	Received

4-EP	Intracranial Infection with Toxoplasma gondii Following Treatment for Hairy Cell Leukaemia and Haemophagocytic Lymphohistiocytosis	Elisabeth Nuttall	Received

4-P	Healthcare Resource Utilisation of Patients With DLBCL Receiving Axicabtagene Ciloleucel in England: a Feasibility Study	Eleonora Lovato	Received

4-EP	Clinical Outcomes in Older Patients with High-Grade B-cell Lymphoma Following Liaison Geriatrics Assessment	Sidhant Seth	Received

4-EP	Phase 1 Study Of Novel CD19×CD3 T-Cell Engager MK-1045 for Relapsed or Refractory Diffuse Large B-Cell Lymphoma	Charlotte Brennan	Received

4-EP	Updated Phase 2 waveLINE-007 Results: Zilovertamab Vedotin Plus R-CHP in Diffuse Large B- Cell Lymphoma	Charlotte Brennan	Received

4-EP	Nemtabrutinib in Relapsed or Refractory Chronic Lymphocytic Leukemia/Small Lymphocytic Lymphoma: Phase 2 BELLWAVE-003 Cohort J	Charlotte Brennan	Received

4-EP	Zilovertamab Vedotin Plus R-CHP Versus R-CHOP for First-Line Treatment of DLBCL: Phase 3 waveLINE-010 Study	Charlotte Brennan	Received

4-EP	MK-3475A-F65 Study: MK-3475A in Relapsed or Refractory Classic Hodgkin or Primary Mediastinal Large B-Cell Lymphoma	Charlotte Brennan	Received

4-P	Phase 1 Study of Novel CD19×CD3 T-Cell Engager MK-1045 for Relapsed or Refractory Follicular Lymphoma	Charlotte Brennan	Received

4-P	Part 1 of the Phase 3 BELLWAVE-010 Study: Nemtabrutinib Plus Venetoclax in Relapsed or Refractory CLL/SLL	Charlotte Brennan	Received

4-P	Phase 2 BELLWAVE-003 Cohort G: Updated Clinical Outcomes of Nemtabrutinib in Relapsed or Refractory Follicular Lymphoma	Charlotte Brennan	Received

4-EP	Patient Characteristics in a DLBCL Cohort Receiving Axicabtagene Ciloleucel in England: A Real-world Feasibility Study	Eleonora Lovato	Received

4-EP	Novel Chronic Lymphocytic Leukaemia Treatments, a District General Hospital real world experience	Ahmad Khoder	Received

4-EP	Zilovertamab Vedotin Plus R-CHP as First-Line Therapy for Germinal Center B-Cell Diffuse Large B-Cell Lymphoma: The Phase 2 waveLINE-011 Study	Charlotte Brennan	Received

4-P	Outcomes for patients with relapsed/refractory primary mediastinal B-cell lymphoma: A single-centre analysis	Yasmin Ingram	Received

4-P	Identifying new potential immunotherapeutic targets in Hepatosplenic T-cell lymphoma (HSTCL)	Rishabh Motiwale	Received

4-EHA26-PO	Beyond the Peaks: Mapping Hemoglobin Variants Using Bio-Rad D-10	Aarthiprabha Ravichandaran	Received

4-EP	Real-World Fixed-Duration Ibrutinib+Venetoclax in Untreated Chronic Lymphocytic Leukemia/Small Lymphocytic Lymphoma: Pooled Analysis of REALITY Studies	Emma Rogers	Received

4-P	Post-hoc safety analysis from Phase 3 AMPLIFY trial comparing fixed-duration acalabrutinib–venetoclax combinations versus chemoimmunotherapy	Ellie John	Received

4-P	Predicting POD24 in previously untreated mantle cell lymphoma patients receiving bendamustine-rituximab with or without acalabrutinib	Ellie John	Received

4-P	Quality of Life With Epcoritamab, Lenalidomide, and Rituximab Treatment in Relapsed/Refractory Follicular Lymphoma (EPCORE FL-1)	Kim Linton	Received

4-P	High mortality in Lymphoma-associated Haemophagocytic Lymphohistiocytosis treated with anakinra: a retrospective UK tertiary hospital analysis.	Richard Williams	Received

4-P	Treatment patterns and outcomes in patients diagnosed with mantle cell lymphoma in England	Betina Blak	Received

4-EP	Updated Phase 2/3 waveLINE-003 Results: Zilovertamab Vedotin Plus SOC in Relapsed/Refractory Diffuse Large B-Cell Lymphoma	Charlotte Brennan	Received

4-EP	Three-year follow-up of Phase 1 first-in-human Surovatamig, a CD19xCD3 T-cell engager, in R/R follicular lymphoma.	Simon Rule	Received

4-EP	Phase 2 BELLWAVE-003 Study Evaluating Acquired Genomic Mutations in Participants With CLL/SLL Treated With Nemtabrutinib	Charlotte Brennan	Received

4-EP	BGB-16673 for Relapsed/Refractory Chronic Lymphocytic Leukemia/Small Lymphocytic Lymphoma: Updates From the Phase 1 CaDAnCe-101 Study	Helen Marr	Received

4-EP	Mosunetuzumab plus Lenalidomide in Relapsed/Refractory Follicular Lymphoma: Phase III CELESTIMO Study US Extension Cohort Results	Mark Bishton	Received

4-P	Variation in timing of first plasma methotrexate monitoring following high-dose therapy across UK cancer services	Shirley Forbes	Received

4-P	Acalabrutinib plus Venetoclax and Rituximab in treatment-naïve (TN) mantle cell lymphoma (MCL): Results from TrAVeRse	Sunil Iyengar	Received

4-EP	Time to third-line treatment after bendamustine-rituximab with or without acalabrutinib in first-line mantle cell lymphoma	Craig Delury	Received

4-EP	When EBV Meets MALT: Histological and Therapeutic Challenges in Coexisting Pulmonary MALT and CNS Lymphomatoid-Granulomatosis	Mohamed Ali	Received

4-EP	Pirtobrutinib(pirto) vs Bendamustine+Rituximab(BR) in CLL/SLL:Randomized phase III study of a non-covalent(nc) BTKi in treatment-naïve(TN) patients	Mal Greaney	Received

4-EP	The East Dorset Experience - A Pilot Lymphadenopathy Investigation pathway	Omotayo Taiwo	Received

4-EP	To B or BVBendamustine, that´s the question!	Olivia Sherwen	Received

4-EP	Bilateral Vitreoretinal Lymphoma with diagnostic challenges, multidisciplinary management ,and Optical Coherence Tomography Guided response assessment	Sumitha Niyomi Nanayakkara	Received

4-EP	Fertility Preservation & Premature Gonadal Failure in Systemic Anti-Cancer Therapy recipients: Are we delivering best-practice?	Laura Anderson	Received

4-EP	Living With & Beyond Lymphoma: Can End Of Treatment (EOT) Nurse-led Clinics Bridge The Gap?	Christina Kirby	Received

4-EP	UK Patient Survey and Evaluation of an Active Monitoring Checklist in Waldenström Macroglobulinemia/Lymphoplasmacytic Lymphoma	Alison McKinney	Received

4-EP	Precision Exercise Training Reduces Frailty in Chronic Lymphocytic Leukaemia: A 12-Week Randomised Controlled Trial	David Bartlett	Received

4-P	FLAIR trial: Ibrutinib plus Rituximab improves survival outcomes compared to FCR in Untreated CLL	Talha Munir	Received

4-EP	Removal of CNS Prophylaxis in LBCL Without Increased CNS Relapse: A Multicentre Retrospective Study	Hannah Bailey	Received

4-EP	Incidental finding of asymptomatic Hairy Cell Leukaemia in context of CLL	Sheree Croxford-Roberts	Received

4-EP	Bone Health Management and Fracture Risk in Steroid-Treated Lymphoma Patients: An Institutional Experience	Sidhant Seth	Received

4-EP	Updated Axicabtagene Ciloleucel Real-World Manufacturing Experience for Diffuse Large B Cell Lymphoma in the UK	Victoria Weston	Received

4-P	Bexobrutideg (NX-5948), a Novel Bruton´s Tyrosine Kinase (BTK) Degrader: Updated Phase 1a/b Trial Findings (WM)	Lee Miller	Received

4-EP	BeGEV Chemotherapy in R/R Hodgkin Lymphoma: A Real-world experience from the West Midlands Research Consortium	Sharadha Sundararaman	Received

4-P	Bexobrutideg (NX-5948), a Novel Bruton´s Tyrosine Kinase (BTK) Degrader: Updated Phase 1a/b Trial Findings (CLL)	Lee Miller	Received

4-EP	Phase 2 Trial of Bexobrutideg (NX-5948) in CLL Patients Previously Exposed to BTKi and BCL2i	Lee Miller	Received

4-EP	Quantitative Fluorescence-Intensity Spectrum Model for CD5?/CD10? B-Cell Neoplasms	Chitranga Kariyawasan	Received

4-EP	Prolonged Severe Neutropenia Following Fixed-Duration Obinutuzumab–Venetoclax Therapy in Chronic Lymphocytic Leukaemia.	Ikram Ul Haq	Received

4-EP	Post-CAR-T Survivorship: Infectious Burden, Cytopaenias, and Immune Recovery in a Regional UK Cohort	Sharanya Ramakrishnan	Received

4-P	Patient mobility for first-line chemotherapy in Diffuse Large B-Cell Lymphoma patients: A national population-based study	Kate Walker	Received

4-EP	Emergency Presentations of Non-Hodgkin Lymphoma in England 2017–2022: National Trends and Variation	Kate Walker	Received

4-EP	Real-World Outcomes of Bispecific Antibodies in Heavily Pretreated Lymphoma and Multiple Myeloma	Faye Lynch Williams	Received

4-EP	Geriatric 8 Frailty Scores and Clinical Outcomes in Elderly Non-Hodgkin Lymphoma	Anastasia Chew	Received

4-EP	Route To Diagnosis Of Mantle Cell Lymphoma: England 2014–2018 (An UNCOVER Group National Cohort Study)	Abigail Martin	Received

4-EP	In people with high-grade transformation of follicular lymphoma, which factors predict good outcomes with immunochemotherapy?	Mia Beattie	Received

4-EP	Relapsed hypopigmented mycosis fungoides masquerading as vitiligo after a prolonged remission	Parth Ganatra	Received

4-EP	OUTCOME OF IBRUTINIB IN CHRONIC LYMPHOCYTIC LEUKEMIA-REAL WORLD EXPERIENCE FROM A DEVELOPING COUNTRY	Nida Anwar	Received

4-EP	EBV-negative Intravascular Large B-cell Lymphoma presenting as Post-Transplant Lymphoproliferative Disorder	Suhani Sharma	Received

4-EP	Real world outcomes of safety and efficacy of Acalabrutinib for Chronic Lymphocytic Leukaemia - A Multicentre Experience	James Clarke	Received

4-EP	Post-Transplant Lymphoproliferative Disorder: A 23-Year Single-Centre Analysis of Clinical Patterns and Long-Term Outcomes	Kian Emami	Received

4-EP	ACALABRUTINIB REAL-WORLD EXPERIENCE IN PATIENTS WITH CLL: ESSEX AUDIT	Dr Shereen Elshazly	Received

5-EP	The use of anticoagulation in paroxysmal nocturnal haemoglobinuria (PNH).	Louise M Arnold	Received

5-P	Rare Haemoglobin Variant Detection in a Large Regional Haemoglobinopathy Centre	Ruby Wolman	Received

5-EP	Lessons from The Infected Blood Inquiry – Long-term Outcomes of Haemoglobinopathy Patients with Hepatitis C	Zoe Kirkham	Received

5-EP	Emergency Department Presentations with Critical Anaemia: An Audit on Hospitalisation and Transfusion Practice	Chen Xi Lee	Received

5-EP	Pathogenic Variants in SLCO2A1 are a Rare Cause of Anaemia	Elisabeth Nuttall	Received

5-EP	Automated Red Cell Exchange in Adult Sickle Cell Disease: Hospital Utilisation and Quality-of-Life Outcomes	Khushnuma Mullanfiroze	Received

5-EP	Dutch Beta Thalassemia: A Rare Case of Non-Transfusion-Dependent Thalassemia in a Young Adult	Shivam Rainchwar	Received

5-EP	A Meta-analysis on Vitamin D Deficiency in Patients with Sickle Cell Disease	Mansour Alawad	Received

5-EP	Pro-inflammatory Cytokines and Derived Haematological Indices as Biomarkers of Inflammation Across Haemoglobin Variants	Ransom Baribefii Jacob	Received

5-EP	"Don´t Let Me Go": Understanding Paediatric-to-Adult Care Transition For Sickle Cell Disease In Ghana.	Eunice Agyeman Ahmed	Received

5-EP	When Vaso-Occlusive Crisis Isn´t The Answer: An Atypical Craniofacial Infection In Sickle Cell Disease	Oluwafunmilayo Akinde	Received

5-EP	Non-Pharmacological Interventions for the Management of Chronic Pain in Sickle Cell Disease: A Narrative Review.	Kleio Kitromilidou	Received

5-EP	Recurring Vaso-Occlusive Crisis Trajectories in Sickle Cell Disease: Longitudinal, Within-Patient Variations in Remotely Tracked Biometrics	Kim Summers	Received

5-EP	Insights From the International PNH Registry: Safety and Effectiveness of Ravulizumab in Advanced-age PNH Patients	Shreyans Gandhi	Received

5-EP	A Novel Pathogenic Variant Of PIEZO1 Causing Familial Dehydrated Hereditary Stomatocytosis	Lily O Keeffe	Received

5-EP	Hypophosphataemia and Bone Loss Following Prolonged Intravenous Iron Therapy: A Case Report	Ghina AL Akoum	Received

5-P	Microcytosis with iron overload: recognising aceruloplasminaemia	Ana Ortuno-Cabrero	Received

5-P	"They call me a curse": Perceived impact of stigma on patient-centred sickle cell disease care	Motto Nganda	Received

5-P	Acquired methaemoglobinaemia secondary GLP-1 agonist. A case report	Mahmoud Bokhary	Received

5-P	Evaluation of Venesection Practice in Genetic Haemochromatosis at University Hospital Birmingham	Yasamin Saidi	Received

5-EP	RBC transfusion to treat or prevent complications in SCD: An overview of cochrane reviews	Alvin Katumba	Received

5-EP	Ferritin and Iron Deficiency in Patients with Long Term Conditions in UK Primary Care	Alvin Katumba	Received

5-P	Danicopan Add-On Therapy Demonstrates Positive Efficacy and Safety in Advanced-Age Adults with PNH and csEVH	Austin Kulasekararaj	Received

5-EP	Improving Adherence to Updated Once-Daily Oral Iron Guidance: A District General Hospital Quality Improvement Project	Sian Warner	Received

5-EP	Assessment of Venesection Practice at SAMOC in Line with BSH Guidelines	Marylou Fenech	Received

5-EP	Door to Analgesia: A Sickle Crisis Audit	Ujjvala Kalluri	Received

5-P	IMPROVING ACCESS, EXPERIENCE, AND OUTCOMES FOR PEOPLE LIVING WITH SICKLE CELL DISEASE	Loretta Achiekwelu	Received

5-EP	Methods of assessing and quantifying fatigue in adults with anaemia: a scoping review	Matthew Poynton	Received

5-P	Beyond the Clinic: Exploring a Community-Designed Wellbeing Hub for Sickle Cell Disease in Liverpool	Ruth Akindele	Received

5-P	Fulminant Fat Embolism Syndrome with Multiorgan Failure in Sickle Cell Disease: A Case Report	Seda Celik	Received

5-EP	Real-World Audit of Hypophosphatemia Following IV Ferric Carboxymaltose	Imali Ediriweera	Received

5-P	Assessing the Appropriateness of Gastroenterology Referrals for Genetic Haemochromatosis patients in a District General Hospital	Hansini Dassanayake	Received

5-EP	Assessment of the Appropriateness of Monofer (Ferric Derisomaltose) Iron Infusions at BHRUT	WING YEE CHRIS SIN	Received

6-EP	Evaluation of digital blood film competency assessment	Tara Maisel	Received

6-EP	The Impact of Early Access to Support and Information Through Referral to Charity Services	Tanya Kumar	Received

6-EP	What Counts as Work? Quantifying Time, Complexity and Value in Haematology Non-Resident On-Call Shifts	Anuradha Bhide	Received

6-EP	Advance Care Planning in Haematology Inpatients: a Retrospective Audit of Treatment Escalation Plan (TEP) Decision-Making	Iarla ODonnell	Received

6-EP	Supporting More People to Access Clinical Trials Using Novel Innovative Approaches	Jane Nunnick	Received

6-P	Liaison Haematology Advice amid NHS Pressures – Are Better Guidelines Needed?	Jonathan Massie	Received

6-P	Blood Cancer in Scotland: We know what it takes, Blood Cancer UK´s Holyrood election manifesto	Josh Hill	Received

6-EP	Blood Cancer in Wales: We know what it takes, Blood Cancer UK´s Senedd election manifesto	Josh Hill	Received

6-P	Addressing the Transfusion Consultant Shortage: Out of Programme Experience for Subspecialty Transfusion Training in England	Suzy Morton	Received

6-P	Community-led strategies to build trust and awareness of blood cancer clinical trials	Khadijha Sundus	Received

6-P	A Call to Action: Creating a Professional Development Framework for and with Transfusion Practitioners	Jennifer Rock	Received

6-P	Streamlining Haematology Patient Flow using an ´Acute Take´ Model	Lucy Rose	Received

6-P	CARE: Cytokine release syndrome and immune effector cell associated neurotoxicity Assessment and Response Evaluation	Hilesa Asiedu	Received

6-EP	Palliative care utilisation in Haematological malignancy inpatients following RePECT decisions A single-centre study	Sumitha Niyomi Nanayakkara	Received

6-P	Algorithm before Referral: Why A+R needs a re-think. A tertiary centres experience.	Sophie Lee	Received

6-P	Patients with myeloproliferative neoplasms value online information more than other forms of support	Patrick Harrington	Received

6-P	Interdisciplinary Team Approach to Straight To Test Ultrasound Meets Faster Diagnostic Standard for New Lymphomas	Micaela Plucinski	Received

6-EP	Understanding the Patient Experience to Optimise Myeloma Clinic Performance: A Quality Improvement Initiative	Philip Kim	Received

6-EP	Development and usability testing of a CAR-T e-Learning resource for HCPs: a qualitative think-aloud study.	Lauren Young	Received

6-EP	Evaluation of Urgent Suspected Cancer Haematology Referrals and Diagnostic Timelines at a Tertiary Centre	Sneha Abburu	Received

6-EP	Connecting Over Coffee: Engaging Sickle Cell and Thalassaemia Communities Through Monthly Research Conversations	Alicia Chevalier	Received

6-EP	Redesigning the TACO Risk Assessment Form: A Quality Improvement Project in Transfusion Practice	Mohid Kamran Malik	Received

6-EP	A Sustainable Virtual Model for Undergraduate Haematology Teaching in Low Resource Settings: A UK-Ghana partnership	Srinivasa Rambhatla	Received

6-EP	Using Buku Medicine to reduce referrals to haematologists by overcoming common human factors	Alex Langridge	Received

6-EP	Do We Assess and Prescribe VTE Prophylaxis Correctly for our Hospital Patients	Dhillon Hirani	Received

6-EP	Quantifying knowledge gained from the UCLH Cancer Academy Pharmacists´ Essential Guide to Haematology Course	Raakhee Shah	Received

6-EP	TrialScout: A Trainee-Developed App for Haematology Clinical Study Information	Sophie Evans	Received

6-EP	An Investigation of UK Healthcare Students´ Knowledge of and Training in Sickle Cell Disease	Yassin Njie	Received

6-EP	Improving Incoming Resident Doctor Confidence in Haematology Placement Induction Through a Structured Handbook	Syeda Liaba Hassan	Received

6-EP	A model for the integration of the Physician Associate role within the haematology workforce	Arya Hajiaghaee	Received

6-EP	An Audit of The Management of Suspected Neutropenic Sepsis	Dhillon Hirani	Received

6-EP	Nurse and Physician Assistant-led Peripheral Blood Next Generation Sequencing Straight-To-Test Clinic Expedites Myeloproliferative Neoplasm Work-up	Nicole Japzon	Received

7-EP	Response rate and duration following different regimens of rituximab for ITP: a single institution study	Mamta Garg	Received

7-P	Upfront romiplostim in acute ITP is an effective option. Data from the UK Adult ITP-Registry	Frederick Chen	Received

7-EP	An Audit Assessing the Diagnostic Yield of Bone Marrow Biopsies Performed by Different Specialties	Midusha Sivaskanthan	Received

7-EP	Review of Outcomes for Women with Immune Thrombocytopaenia in Pregnancy over a Twelve Year Period	Gavin OToole	Received

7-EP	Refractory AIHA in Pregnancy: Ulcerative colitis as a driver and the role of biologic therapy	Jimmy William	Received

7-EP	Adult-onset Life Threatening HLH successfully treated with TNLI/ATG-Conditioned Allogenic Stem Cell Transplant	Akhil Khera	Received

7-EP	Optimising Faster Diagnostic Standards (FDS) for suspected haematological malignancies by implementation of consultant-led triage	Melissa Truman	Received

7-EP	Early use of avatrombopag in newly diagnosed patients with ITP- a single centre experience	Dinesh Ranasinghe	Received

7-EP	Diagnostic Yield of Bone Marrow Biopsy Following Abnormal Marrow Signal on Imaging: Single-Centre Retrospective Audit	Janet Tan	Received

7-EP	A Haematological Masquerade: Megaloblastic Anaemia mimicking Acute Leukaemia	Smrithi Anil Nayak	Received

7-P	Vitamin D Monitoring and Replacement in Stem Cell Transplantation: Audit of Compliance with Guidelines	Maeve OShea	Received

7-EP	Optimising Referral Pathways for Patients with Splenomegaly: A Two-Cycle Quality Improvement Project in Haematology Services	Ahmed Butt	Received

7-EP	Management of Idiopathic and Secondary Erythrocytosis in a Nurse-Led Venesection Clinic: UK Single Centre Experience	Priya Sriskandarajah	Received

7-EP	Anti-IH Antibody Complicating Pre-transfusion Compatibility Testing during Pregnancy	Udeshika Weerabaddana	Received

7-EP	Bernard–Soulier Syndrome in Pregnancy: Haemostatic Challenges overcome by Multidisciplinary Management	Udeshika Weerabaddana	Received

7-EP	Patient Experience of Ravulizumab and Reasons for Treatment Twitching in Paroxysmal Nocturnal Haemoglobinuria	Helena Vincentelli	Received

7-EP	Sharing good practice: an audit cycle of JAK2 testing at a large London teaching hospital.	Myat Noe Oo	Received

7-EP	Extreme thrombocytosis in patients with malignancy; complications, management and outcomes.	Laura McDonald	Received

7-EP	Changes to Pregnancy/postpartum Thromboprophylaxis Practice at UCLH in response to the MBRRACE Report (2024)	Nithya Prasannan	Received

7-EHA26-PO	The Role of Targeted Next Generation Sequencing in Risk Stratification of Myeloma and Treatment Implications	Alicia Gilliat	Received

7-P	Re-audit of Corticosteroid Use in Immune Thrombocytopenia Following Steroid Bundle Implementation at a Tertiary Centre	Micky Tsui	Received

7-P	Psychological Morbidity in iTTP: A UK Registry Study of Depressive Symptoms and Influencing Factors	Dom Smetham	Received

7-P	A case report of patient with Type2N VWD, who also developed Anti-phospholipid syndrome-Management of pregnancy	Shulakshana Soondron	Received

7-P	Patients´ Experiences with Avatrombopag for Immune Thrombocytopaenia in an Irish District General Hospital Setting	Gavin OToole	Received

7-P	Causes of erythrocytosis seen in 10-months of referrals to a large tertiary hospital in London	Myat Noe Oo	Received

7-P	Barriers to the reimbursement of blood cancer treatments in England and Wales	Katie Begg	Received

7-P	A single centre experience of adult outpatient monitoring of ITP: patient burden and future improvements	Sana Saleem	Received

7-P	Efficacy of Mycophenolate Mofetil in ITP according to lines of therapy: a single centre experience.	olga. Tsiamita	Received

7-P	PNH Testing in the West of Scotland - Time for a Re-think?	Robert Osborn	Received

7-EP	THE VALUE OF MODIFIED SIRIUS RED STAIN IN INTERPRETING BONE MARROW TREPHINE BIOPSIES	Salam Al-Sam	Received

8-EP	Beta blockers and ACE inhibitors as modulators of Intravenous Iron Hypersensitivity reactions: A Scoping Review	Jessica Knight	Received

8-P	A Morphologic Mimic: Histiocytic Hyperplasia in Acute Marrow Suppression of a patient with Klebsiella Sepsis	Kumari Perera	Received

8-EP	Too Much, Too Soon? Optimising Myeloid NGS Testing in Suspected MPN	Sailesh Kandasamy	Received

8-EP	A Departmental Retrospective Audit Evaluating Bone Marrow Sample Quality Using Manual Versus Driver-Assisted Techniques.	Eman Mohamedalamin	Received

8-EP	Transfusion risk in sub-Saharan Africa: challenges in DR Congo	Lambert Morisho Mulakwa	Received

8-EP	Acute Blood Transfusion Reactions: A Retrospective Analysis Of Military Hospital Hemovigilance Data From Saudi Arabia	Uzma Rasool	Received

8-P	Improving Compliance for Blood Transfusion Consent: a Quality Improvement Project	Kate Matthews	Received

8-P	A service evaluation of BCR::ABL1 requesting at Sheffield Teaching Hospitals (STH) from 2022-2025.	Sebastian Francis	Received

8-P	Patient Understanding of Consent for Blood Transfusion: A Cross-Sectional Audit	Jessica Knight	Received

8-P	Improving Ro availability for Ro patients; could our experience mitigate national demand and supply problem?	Tracy Hui	Received

8-P	Releasing Capacity in Hospital Clinics by Enabling People with Haemochromatosis to Donate Blood in Wales	joanne gregory	Received

8-EP	TRACKING THE HIDDEN SIGNATURES OF HEMOGLOBIN: A BIO-RAD D-10 ANALYSIS	Aarthiprabha Ravichandaran	Received

8-P	Laboratory and Clinical Implications of Implementation of Incorrect Age-Related D-Dimer Cut-Off in a UK Centre	Praharsh Babu	Received

8-P	Action research to develop a model for voluntary non remunerated blood donation	Kenneth Charles	Received

8-P	Big Data in Transfusion Medicine: Understanding Patient Blood Management	Paula Dhiman	Received

8-P	Validation of an Automated Audit Process for Tranexamic Acid Use in Surgery	Muhammad Naim bin Che Rahimi	Received

8-EP	Pilot Evaluation of a Novel Blood Cleaning Device on Deformability in Stored Red Blood Cells	Agnese Tiranti	Received

8-EP	Can AI Replace the Human Eye in Fetomaternal Haemorrhage Estimation?	Aobh OHagan	Received

8-EP	Closed-Loop Audit of Blood Transfusion Sample Rejection in Emergency Department of a District General Hospital	John Appiah	Received

8-EP	Routine Preoperative Coagulation Screening at Hull University Teaching Hospitals (HUTH) – a clinical audit	Hunter Mangleburg	Received

8-EP	Service Evaluation of Acute Myeloid Leukaemia using appropriate genetic risk stratification	Amardass Dhami	Received

8-P	Comparative preclinical assessment of Surovatamig (AZD0486) versus CD20xCD3 bispecific antibodies	Rachel Lawrence	Received

8-EP	Platelet Parameters in a cohort of Chronic Kidney Disease Patients in a tertiary care hospital	Sumudu Udayangani	Received

8-EP	A Comparative Audit of Trust Transfusion Practice, University Hospitals Birmingham	Niamh Reynaud	Received

8-EP	Hereditary persistence of foetal haemoglobin and false positive Kleihauer test; a case report	Thamodini Prasanga Abeykoon	Received

8-EP	Successful management of Anti- HPA-3a antibody related alloimmune thrombocytopenia in second pregnancy; a case report	Thamodini Prasanga Abeykoon	Received

8-EP	Transfusion management in non-traumatic code red calls for adults at King´s College Hospital	Elizabeth Marrinan	Received

8-EP	An Audit Reviewing Completion Of Midlands Integrated Reporting for Haemato-Oncology (MIHRO) Flow Cytometry Request Forms.	Mashal Qureshi	Received

8-EP	Outcomes of a Haematological Oncology Diagnosis Service using a networked laboratory approach: review of 600cases	Suzanne Arulogun	Received

8-EP	Assessment of Fibrinogen in FFP and Cryoprecipitate Processed at a Regional Blood Centre Sri Lanka	Aruni Ratnapala	Received

8-EP	Use of HLA Matched Platelets at a Large UK Tertiary Centre	Lubna Awas	Received

8-EP	Use of Red cells, Platelets, Fresh Frozen Plasma and Cryoprecipitate in Neonates- a Single-centre Audit	Devi Purushothaman	Received

8-EP	Lymphocytosis Referrals: Are Current Thresholds Overburdening Haematology Services?	Khalid Shedeed	Received

8-P	Audit of Urgent Therapeutic Apheresis Referrals in NHSBT: Appropriateness, Completeness and Guideline Alignment	Matthew Hazell	Received

8-P	Waste not, want not: How are red cell units ordered for haemoglobinopathy patients being used?	Deborah Awogbade	Received

8-EP	General Practitioners Knowledge and Interprestation of Blood Film Comments from a Haematology Laboratory	Sumaya Elhanash	Received

9-P	Galectin-1 as a Mediator of Thrombotic Risk in Myeloproliferative Neoplasms	Natalie Jooss	Received

9-P	Cerebral Venous Sinus Thrombosis in Antiphospholipid Syndrome – Experience from a single national treatment centre	Pritom Dey	Received

9-EP	Gynaecological Care and Iron Deficiency in Girls and Women with Bleeding Disorders: UK National Variability	Lugain Abdalla	Received

9-EP	Direct Oral Anticoagulant Use in Patients with Obesity (>120kg) for Atrial Fibrillation: A Retrospective Study	Aiman Entwistle	Received

9-EP	Daratumumab: Turning the Tide in Refractory TTP	Jimmy William	Received

9-EP	Right Indication, Right Timing, Right Retrieval: A Quality Improvement Project on IVC Filter Outcomes	Mohamed Zahran	Received

9-EP	Utility of the PLASMIC Score in Early Triage of Suspected TTP: A Regional Centre Experience.	Muhammad Anas Memon	Received

9-P	A novel histone-nanofiber dressing (HIST-CEL) for rapid haemostatic control in trauma.	Jun Yong	Received

9-EP	Congenital Afibrinogenemia: The Double-Edged Sword of Bleeding and Thrombosis – Lessons from Three South-Indian Cases	Michael L J Pais	Received

9-EP	Anticoagulation in the Management of Left Ventricular Thrombosis: Data Review from a Tertiary Cardiology Centre?	Aisling Eves	Received

9-EP	Improving Patient Awareness of Breast Cancer-Associated Thrombosis and Its Prevention - A Quality Improvement Project	Nicole Coomer	Received

9-EP	Tumour Thrombosis and Coexisting Venous Thromboembolism in Cancer: Anticoagulation Intensity in a Retrospective, Multi-site Cohort	Anastasia Chew	Received

9-EP	Aetiology, Treatment, and Outcomes of Splenic Infarction in a Multicentre Retrospective Cohort	Anastasia Chew	Received

9-EP	An Audit to Assess Venous Thromboembolism Prevention Management following Hip Fracture Surgery	Anastasia Chew	Received

9-EP	An Audit to Assess Venous Thromboembolism Prevention Measures in People Undergoing Transgender Surgery	Anastasia Chew	Received

9-EP	When Cytopenias Signal More: Thrombotic Microangiopathy After Trastuzumab-Emtansine Therapy	Seemal Abdulqadir	Received

9-EP	A Review of Oral Anticoagulation Management and Clinical Impact in Patients Receiving Rifabutin	Anastasia Chew	Received

9-EP	An Audit to Assess Venous Thromboembolism Prevention Measures in Bariatric Surgery	Anastasia Chew	Received

9-EP	A Retrospective Analysis of Haemostasis and Thrombosis Advice and Guidance Requests at University Hospitals Leicester	Dhylan Patel	Received

9-EP	Use of fondaparinux for long-term haemodialysis circuit patency in a patient with previous heparin-induced thrombocytopenia	Elizabeth Marrinan	Received

9-EP	Investigating the effectiveness of different thromboprophylaxis agents in preventing thrombotic events in MPNs	Shourya Sharma	Received

9-EP	Ovarian Vein Thrombosis: An under-recognised and potentially life-threatening cause of venous thromboembolism	Rebecca Walsh	Received

9-EP	Apixaban versus Dalteparin in Superficial Thrombophlebitis A Retrospective Cohort Analysis	Katherine Stark	Received

9-EP	Low-Dose Rituximab Treatment in Idiopathic Thrombocytopenic Purpura Assessed by Immature Platelet Fraction Monitoring	Alssa Alvi	Received

9-EP	Perioperative Use of Thrombopoietin Receptor Agonists in Chronic Immune Thrombocytopenia	Priyanta Banerjee	Received

9-EP	Thrombotic microangiopathy following electrochemotherapy for breast cancer: a first report.	Dreen Gul	Received

9-EP	A Two-Cycle Audit of the Use of Eltrombopag at Nottingham University Hospitals NHS Trust	Nicholas Yew	Received

9-EP	A Young Male with Recurrent Myocardial Infarction and Pulmonary Embolism: Unmasking Antiphospholipid Syndrome	Wanni Achchi Pathirannahelage Dona Punsisi Madhushani Nissanka	Received

9-EP	Comparative assessment of Anti-CD20 therapies in treating ADAMTS13 relapse	Gabriella Marie	Received

9-EP	Prevalence of Thrombotic Events in Patients with Antiphospholipid Syndrome: Experience from a national referral centre	Andrew Doyle	Received

9-EP	Establishing Primary-Care Haemophilia Baselines and Potential Opportunities for Severity-Focused Data Augmentation	Kim Summers	Received

9-EP	Overdiagnosis of Heparin-Induced Thrombocytopenia: 4Ts Score Utilisation and Laboratory Test Reliance at a tertiary centre	Maryam El-Chgar	Received

9-P	Outcomes in Paediatric Patients with HSCT-TMA Treated With Ravulizumab	Sarah Lawson	Received

9-EP	Testing practice of Lupus Anticoagulant in a District General Hospital in the UK	Maduwanthi Jayaweera	Received

9-EP	Thromboprophylaxis in severe autoimmune haemolytic anaemia: an audit of LMWH use and VTE	Sivappriyan Nagarajah	Received

9-EHA26-PO	Outcomes of Venetoclax and Azacitidine in Relapsed Acute Myeloid Leukaemia: A Single-Centre Retrospective Study	Danyal Khan	Received

9-P	Preoperative Coagulation Panels in Elective Surgery: A Costly Habit	Marylou Fenech	Received

9-EP	Patient Refusal of Venous Thromboembolism Prophylaxis and its Potential Impact?	Huw Rowswell	Received

9-EP	Improving Adherence to Tranexamic Acid Guidelines During Elective Surgery	James Flynn	Received

9-P	BEYOND ABR: Joint health and Physical Activity in People with Haemophilia A Switching to Emicizumab	Helen Miller	Received

9-P	FREEDOM trial: 12-month Interim Analysis in Patients with Severe Haemophilia A Treated with Efanesoctocog Alfa	Mark Kenneth Smith	Received

9-P	Efanesoctocog Alfa in Patients with Severe Haemophilia A: European Results from XTEND-ed Third Interim Analysis	Jayashree Motwani	Received

9-P	Direct oral anticoagulants provide effective thromboprophylaxis in newly diagnosed myeloma: Real world findings from ATOMM	Tom Bull	Received

9-P	Comparison of Coagulation Profiles between Fibrinogen Concentrate and Cryoprecipitate in Patients Undergoing Major Abdominal Surgery	Jessica Payne	Received

9-P	NXT007 Prophylaxis in People with Haemophilia A with/without Inhibitors: A Global Phase I/II Study	Helen Miller	Received

9-EP	"Nobody Really Gets It the Same": Exploring Caregiver Burden in Haemophilia with Inhibitors	Natasha Vernon	Received

9-P	Mim8 prophylaxis in children with haemophilia A: 52-week efficacy and safety outcomes from FRONTIER3	Samya Obaji	Received

9-P	Mim8 prophylaxis in adults and adolescents with haemophilia A: FRONTIER2 52-week efficacy and safety outcomes	Samya Obaji	Received

9-P	FRONTIER5 direct switch study: Safety of initiating Mim8 prophylaxis without washout of emicizumab	Samya Obaji	Received

9-P	Qualitative Insights into Educational Challenges facing UK Children and Adults Living with Haemophilia and Inhibitors	Bekki Millward	Received

9-P	Analysis of 369 Variants Within an ADAMTS13 Database Extends Understanding of Congenital TTP	Matthew Carter	Received

9-EP	Evaluation of Coagulation Profile in Patients with Chronic Liver Disease in Abakaliki, Southeast Nigeria	Oluomachi Charity Nnachi	Received

9-P	PCC-FAST: Prothrombin Complex Concentrate - Follow-up Audit of the Service and Timeliness of administration	Charlotte Claydon	Received

9-EP	Compliance with Venous Thromboembolism Prophylaxis Protocol in Surgical Patients in Letterkenny University Hospital, Donegal, Ireland	Katie Foran	Received

9-EP	Real world experience of DOACS for paediatric thrombosis at a UK tertiary centre	Hannah Bielby	Received

9-EP	Case Report of a Pembrolizumab-induced Thrombotic Thrombocytopenic Purpura	Danushka Dissanayaka	Received

10-EP	Clinical Profile of Children with Sickle Cell Disease managed in Oman: 10 Years´ Experience	Anwar Alshibli	Received

10-EP	Immune thrombocytopenia in babies under 3 months of age: a case series	Wai Ka Natalie Leung	Received

10-P	Paroxysmal nocturnal haemoglobinuria in paediatric patients: a UK experience	Morag Griffin	Received

10-P	Audit of thrombocytosis in paediatric patients	Jonathan Quinn	Received

10-P	Role of ISTH BAT score in children referred to tertiary paediatric bleeding disorder clinic	Rachit Mathur	Received

10-P	The role of RNA-sequencing to improve fusion gene detection and MRD monitoring in TYA ALL	Athanasia Sinti Papadaki	Received

10-P	Global variation in the management of testicular relapse in paediatric and teenagers and young adults.	Olya OConnor	Received

10-P	A successful implementation of once weekly Factor VIII prophylaxis in a Paediatric Haemophilia Centre	Chris Curry	Received

10-P	An Audit on the Effectiveness of Emicizumab in Patients with Severe Haemophilia A	Sabah Ahmed	Received

10-P	Bone Density and Vertebral Fractures in Teenage and Young Adult Patients with Acute Lymphoblastic Leukaemia	Aidan Kirk	Received

10-EP	Secondary Histiocytic Sarcoma Presenting as an Unusual Iliac Lesion in Paediatric B-ALL	Mereta Ann Varughese	Received

10-EP	Audit of special requirements in paediatric transfusion	Jonathan Quinn	Received

10-EP	Beyond Affordability: Ensuring Every Child with Leukemia Has Access to Immunophenotyping	John Appiah	Received

10-EP	Platelet indices as low-cost paediatric biomarkers in Yemen: a hospital-based pilot study	Ala Ba wazir	Received

10-EP	Rivaroxaban use in paediatric venous thrombosis: a single-centre retrospective review	Christopher Mullen	Received

10-EP	Epidemiology and Cutaneous Manifestations of Sickle Cell Anemia:Transfusion Challenges in Resource-Limited Settings	Shambhu Joshi	Received

10-EP	Thrombopoietin Receptor Agonist Use in Paediatric Immune Thrombocytopenia: A Single-Centre Experience	Jeremy Schofield	Received

10-EP	Successful Stem Cell Transplant in a Child with Seckel Syndrome and Refractory T-Cell Lymphoblastic Leukaemia	Rachael Campbell	Received

10-EP	Management of children with inherited bleeding disorders (IBD) in a tertiary paediatric emergency department	Abdul Wajid Moothedath	Received

10-EP	Challenging Acquired Immune Thrombotic Thrombocytopenic Purpura (iTTP): A Case Highlighting Atypical Treatment Decisions	Khalid Shedeed	Received

10-EP	A Quality Improvement Algorithm for Urinary pH Monitoring during High-Dose Methotrexate (HD-MTX) Administration	Grace Coyne	Received

10-EP	The Acute Management of Children presenting with Elevated White Cell Counts: A Single Centre Experience	Susan Wallace	Received

10-EP	Use of hydroxyurea in children with sickle cell disease in Edinburgh: a pilot service evaluation	Noon Abdelrazig	Received

10-EP	Reduction of Time to Analgesia in Sickle Cell Patients through Implementation of Digital Care Plans	Sarah Anne Wai Mun Yip	Received

66th Annual Scientific Meeting of the British Society for Haematology

19-21 April, Liverpool

Help Line

Homepage

Personal Area

Search and consult posters online
in an exclusive section
for each poster

ACTIVE FROM 17/04/2026 TO 19/04/2027

Poster
Gallery

Upload
Poster

Featured Poster

Vote poster

Poster Discussion
Forum



		Digital Object Identifier. Official code used to identify documents published on internet; similar to ISBN for books. You may use this code to reference your poster in future scientific publications or CVs. It can be found from anywhere in the world. To find the poster page, log onto www.medra.org and enter the DOI, or enter in your internet browser https://dx.doi.org/ followed by the DOI string asigned to your congress.

About us

Terms and Conditions